UPPLUS Trademark

Trademark Overview


On Wednesday, October 21, 2020, a trademark application was filed for UPPLUS with the United States Patent and Trademark Office. The USPTO has given the UPPLUS trademark a serial number of 79298631. The federal status of this trademark filing is REGISTERED as of Tuesday, February 22, 2022. This trademark is owned by APEX BIOTECH RESEARCH PTY LTD. The UPPLUS trademark is filed in the Pharmaceutical Products category with the following description:

Nutritionally fortified herbal beverages for medicinal use; Nutritionally fortified medicated beverages; Nutritionally fortified medicinal beverages for medical purposes; Vitamin enriched sparkling water for medical purposes; Nutritionally fortified water for medical purposes; Vitamin enriched water for medical purposes; disinfectants for hygiene purposes; Medicated products for oral hygiene, namely, medicated toothpaste; Medicated mouthwash for oral hygiene purposes; Preparations for oral hygiene, namely, medicated toothpaste, other than dentifrices; Preparations for personal hygiene, namely, disinfectants; Disinfectants for hygienic purposes; Acne treatment preparations in the form of cleansers; Acne treatment preparations in the form of creams; anti-bacterial pharmaceutical preparations; Chemical products for pharmaceutical use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the ma...
upplus

General Information


Serial Number79298631
Word MarkUPPLUS
Filing DateWednesday, October 21, 2020
Status700 - REGISTERED
Status DateTuesday, February 22, 2022
Registration Number6648775
Registration DateTuesday, February 22, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2021

Trademark Statements


Goods and ServicesNutritionally fortified herbal beverages for medicinal use; Nutritionally fortified medicated beverages; Nutritionally fortified medicinal beverages for medical purposes; Vitamin enriched sparkling water for medical purposes; Nutritionally fortified water for medical purposes; Vitamin enriched water for medical purposes; disinfectants for hygiene purposes; Medicated products for oral hygiene, namely, medicated toothpaste; Medicated mouthwash for oral hygiene purposes; Preparations for oral hygiene, namely, medicated toothpaste, other than dentifrices; Preparations for personal hygiene, namely, disinfectants; Disinfectants for hygienic purposes; Acne treatment preparations in the form of cleansers; Acne treatment preparations in the form of creams; anti-bacterial pharmaceutical preparations; Chemical products for pharmaceutical use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Chemicals for pharmaceutical use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for animals for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for application to the skin for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; pharmaceutical preparations for health care for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; pharmaceutical preparations for human use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; pharmaceutical preparations for nasal use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; pharmaceutical preparations for oral use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; pharmaceutical preparations for personal use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for topical use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; pharmaceutical preparations for veterinary use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; pharmaceutical preparations in the form of emulsions for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; pharmaceutical preparations in the form of throat lozenges and medicated lozenges; pharmaceutical preparations in the form of tablets for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; pharmaceutical products for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; pharmaceutical products derived from natural sources for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; pharmaceutical tonic preparations for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; plant extracts for pharmaceutical purposes; plant extracts for pharmaceutical use; Pharmaceutical preparations in the nature of plant extracts for pharmaceutical use; propolis for pharmaceutical purposes; Drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; medicated mouth spray; mouth sprays for medical use; Anti-inflammatory sprays for the body for medical use; sprays for use on the body namely, medicaments for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Acne treatment sprays for use on the body; medicated mouthwashes; medicated antiseptic mouthwashes; medical mouthwashes; mouthwashes and gargles for medical purposes; mouthwashes for medical purposes; eye drops; throat lozenges for pharmaceutical purposes; medicated throat lozenges; medical toothpastes; medicated toothpaste
Pseudo MarkUP PLUS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 2, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAPEX BIOTECH RESEARCH PTY LTD
Party Type30 - Original Registrant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Party NameAPEX BIOTECH RESEARCH PTY LTD
Party Type20 - Owner at Publication
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Party NameAPEX BIOTECH RESEARCH PTY LTD
Party Type10 - Original Applicant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Trademark Events


Event DateEvent Description
Tuesday, August 16, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 27, 2022FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 27, 2022FINAL DISPOSITION PROCESSED
Sunday, May 22, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 22, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, December 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 7, 2021PUBLISHED FOR OPPOSITION
Monday, December 6, 2021NOTIFICATION PROCESSED BY IB
Wednesday, November 17, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 17, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 1, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, April 25, 2021REFUSAL PROCESSED BY IB
Monday, April 5, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 5, 2021REFUSAL PROCESSED BY MPU
Monday, March 29, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, March 28, 2021NON-FINAL ACTION WRITTEN
Monday, March 22, 2021ASSIGNED TO EXAMINER
Tuesday, December 8, 2020APPLICATION FILING RECEIPT MAILED
Wednesday, December 2, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 26, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB